Resources
- sort by:
- Relevance
- Date
- Popularity
- Elan Corporation, PLC Acquires Rights To Athena Neurosciences' Diastat Development Program
- SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--June 4, 1996-- Athena Neurosciences, Inc. ("Athena")(Nasdaq: ATHN) announced today that Elan Corporation, plc ("Elan") has purchased for six million dollars the rights of PaineWebber R&D Partners III, L.P. (the "Fund") in Athena's Diastat development program.Diastat is a proprietary gel formulation of diazepam intended for rectal...
- Research articles 1996-06-04
- << Previous
- page 1 of 1
- Next >>